|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
731,500,000 |
Market
Cap: |
321.86(M) |
Last
Volume: |
141,003 |
Avg
Vol: |
140,617 |
52
Week Range: |
$0.4199 - $1.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Northwest Biotherapeutics is a biotechnology company focused on developing personalized immune therapies for cancer. Co. has developed a platform technology, DCVax®, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. Co.'s primary product, DCVax®-L, is designed to treat solid tumor cancers in which the tumor can be surgically removed. This product is in a 331-patient Phase III trial for newly diagnosed Glioblastome multiforme. Co.'s second product, DCVax®-Direct, is designed to treat inoperable solid tumors. Co. is working on preparations for Phase II trials of DCVax-Direct in various cancers, when resources permit.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
570,000 |
570,000 |
Total Sell Value |
$0 |
$0 |
$469,430 |
$469,430 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
2 |
2 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Boynton Alton L |
Chief Executive Officer |
|
2010-01-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
82,280 |
1,874,355 |
|
- |
|
Boynton Alton L |
Chief Executive Officer |
|
2010-01-04 |
4 |
A |
$0.20 |
$27,604 |
D/D |
138,020 |
1,956,635 |
|
- |
|
Boynton Alton L |
Chief Executive Officer |
|
2009-12-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
419,270 |
2,234,627 |
|
- |
|
Boynton Alton L |
Chief Executive Officer |
|
2009-11-27 |
4 |
A |
$0.20 |
$46,354 |
D/D |
231,770 |
2,612,183 |
|
- |
|
Boynton Alton L |
Chief Executive Officer |
|
2009-11-07 |
4 |
A |
$0.20 |
$83,854 |
D/D |
419,270 |
2,380,393 |
|
- |
|
Boynton Alton L |
Chief Executive Officer |
|
2009-10-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
150,083 |
1,961,123 |
|
- |
|
Hemphill Robert F Jr. |
10% Owner |
|
2009-09-30 |
4 |
B |
$0.20 |
$352,500 |
I/I |
1,762,500 |
10,309,780 |
1.5 |
- |
|
Hemphill Robert F Jr. |
10% Owner |
|
2009-09-30 |
4 |
A |
$0.20 |
$150,000 |
I/I |
750,000 |
3,322,710 |
|
- |
|
Hemphill Robert F Jr. |
10% Owner |
|
2009-09-28 |
4 |
A |
$0.20 |
$552,738 |
I/I |
2,763,691 |
8,547,280 |
|
- |
|
Hemphill Robert F Jr. |
10% Owner |
|
2009-09-28 |
4 |
A |
$0.20 |
$1,156,718 |
I/I |
5,783,589 |
5,783,589 |
|
- |
|
Toucan Partners, Llc |
10% Owner |
|
2007-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
6,860,561 |
2,572,710 |
|
- |
|
Toucan Partners, Llc |
10% Owner |
|
2007-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
15,011,635 |
15,011,635 |
|
- |
|
Boynton Alton L |
President & COO |
|
2007-03-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000,000 |
3,046,000 |
|
- |
|
Boynton Alton L |
President & COO |
|
2007-01-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
550,000 |
4,046,000 |
|
- |
|
Boynton Alton L |
President & COO |
|
2006-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
4,596,800 |
|
- |
|
Boynton Alton L |
President & COO |
|
2006-05-17 |
4 |
GD |
$0.25 |
$60,000 |
D/D |
240,000 |
4,646,800 |
|
- |
|
Northwest Hospital |
10% Owner |
|
2003-12-16 |
4 |
S |
$0.25 |
$3,641 |
D/D |
(14,565) |
1,891,937 |
|
- |
|
Northwest Hospital |
10% Owner |
|
2003-10-27 |
4 |
S |
$0.25 |
$3,641 |
D/D |
(14,565) |
1,906,502 |
|
- |
|
Northwest Hospital |
10% Owner |
|
2003-10-20 |
4 |
S |
$0.25 |
$3,641 |
D/D |
(14,565) |
1,921,067 |
|
- |
|
Northwest Hospital |
10% Owner |
|
2003-10-14 |
4 |
S |
$0.25 |
$3,641 |
D/D |
(14,565) |
1,935,632 |
|
- |
|
Northwest Hospital |
10% Owner |
|
2003-10-10 |
4 |
S |
$0.25 |
$3,641 |
D/D |
(14,565) |
1,950,197 |
|
- |
|
Northwest Hospital |
10% Owner |
|
2003-09-29 |
4 |
S |
$0.25 |
$3,641 |
D/D |
(14,565) |
1,964,762 |
|
- |
|
Northwest Hospital |
10% Owner |
|
2003-09-22 |
4 |
S |
$0.28 |
$4,078 |
D/D |
(14,565) |
1,979,327 |
|
- |
|
Northwest Hospital |
10% Owner |
|
2003-09-15 |
4 |
S |
$0.25 |
$3,641 |
D/D |
(14,565) |
1,993,892 |
|
- |
|
Northwest Hospital |
10% Owner |
|
2003-09-12 |
4 |
S |
$0.25 |
$3,641 |
D/D |
(14,565) |
2,008,457 |
|
- |
|
112 Records found
|
|
Page 4 of 5 |
|
|